ArticleInhalation2017
A novel aerodynamic sizing method for pharmaceutical aerosols using image-based analysis of settling velocities.
Article in Inhalation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 5 citations in OpenAlex.
- Aerosol Pollutants and Health: Role of Size and Chemical Composition.Public health challenges · 2025Review
- Imaging and Non-imaging Analytical Techniques Used for Drug Nanosizing and their Patents: An Overview.Recent patents on nanotechnology · 2024Review
- Image Analysis: A Versatile Tool in the Manufacturing and Quality Control of Pharmaceutical Dosage Forms.Pharmaceutics · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
This article discusses a novel method to estimate aerodynamic particle size distributions (APSDs) of pharmaceutical aerosols through direct measurement of particle settling velocities using image-based analysis and particle tracking techniques. This simple, optical method provides accurate and fast measurements (approximately 1 minute) with few sources of bias due to specific device design choices or operation conditions. A proof-of-concept for the method is demonstrated by measuring APSDs for widely available commercial dry powder inhalers (DPIs), then comparing the results with previously published data from cascade impactors (CIs) and the Aerodynamic Particle Sizer (APS).
Identifiers
28690715PMC5500172W3003395950What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.